In contrast, dasatinib and saracatenib treatment had no effect on junction integrity and strength in primary tumor cells isolated from Pdx1-Cre; KrasG12D; p53−/−; E-cadherin-GFP mice (Figures S5F and S6I), which inherently possess high junction strength and integrity. This evidence concerns the gene CDH1 and neoplasm.